These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11511764)

  • 21. Refractory Behçet's disease treated with low-dose interleukin-2: A case report.
    Zhou W; Liu T; Xiao X; He J
    Medicine (Baltimore); 2022 Oct; 101(42):e31173. PubMed ID: 36281176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
    Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apremilast in Refractory Behçet's Syndrome: A Multicenter Observational Study.
    Vieira M; Buffier S; Vautier M; Le Joncour A; Jamilloux Y; Gerfaud-Valentin M; Bouillet L; Lazaro E; Barete S; Misery L; Gobert D; Goulenok T; Fain O; Sacre K; Sève P; Cacoub P; Comarmond C; Saadoun D
    Front Immunol; 2020; 11():626792. PubMed ID: 33613571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing the symptoms of Behçet's disease.
    Evereklioglu C
    Expert Opin Pharmacother; 2004 Feb; 5(2):317-28. PubMed ID: 14996628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thalidomide in the treatment of aphthosis and Behçet's disease. 4 years' experience].
    Torras H; Lecha M; Mascaró/ JM
    Med Cutan Ibero Lat Am; 1982; 10(2):103-112. PubMed ID: 6759802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood Behçet's disease: clinical features and comparison with adult-onset disease.
    Krause I; Uziel Y; Guedj D; Mukamel M; Harel L; Molad Y; Weinberger A
    Rheumatology (Oxford); 1999 May; 38(5):457-62. PubMed ID: 10371286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Behçet's disease with thalidomide.
    Hamza MH
    Clin Rheumatol; 1986 Sep; 5(3):365-71. PubMed ID: 3780143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G; Ben-Chetrit E
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of Behçet's disease in children.
    Borlu M; Ukşal U; Ferahbaş A; Evereklioglu C
    Int J Dermatol; 2006 Jun; 45(6):713-6. PubMed ID: 16796634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behçet's disease].
    Brand HS; van Beusichem FF; van Nieuw Amerongen A
    Ned Tijdschr Tandheelkd; 2008 Jun; 115(6):340-5. PubMed ID: 18618988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
    Rotondo C; Lopalco G; Iannone F; Vitale A; Talarico R; Galeazzi M; Lapadula G; Cantarini L
    Mediators Inflamm; 2015; 2015():451675. PubMed ID: 26185360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behçet's disease.
    Yesudian PD; Edirisinghe DN; O'Mahony C
    Int J STD AIDS; 2007 Apr; 18(4):221-7. PubMed ID: 17509169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome.
    Hamuryudan V; Hatemi G; Sut N; Ugurlu S; Yurdakul S; Yazici H
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S32-4. PubMed ID: 22935508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behçet's syndrome. The Cerrahpasa experience. Members of the Behçet's Syndrome Research Centre.
    Yazici H; Fresko I; Hamuryudan V; Mat C; Melikoglu M; Ozyazgan Y; Tuzun Y; Yurdakul S
    Adv Exp Med Biol; 1999; 455():135-40. PubMed ID: 10599334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of severe colitis in Behçet's syndrome with thalidomide (CG-217).
    Larsson H
    J Intern Med; 1990 Oct; 228(4):405-7. PubMed ID: 2266351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
    Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
    Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
    Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.
    Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H
    Ann Intern Med; 1998 Mar; 128(6):443-50. PubMed ID: 9499327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of paediatric neuro-Behçet's disease: a single tertiary centre experience.
    Cakar N; Başaran O; Uncu N; Güven A; Cayci FS; Acar Çelikel B; Taktak A; Gür G
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S165-70. PubMed ID: 25005687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.